news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

reprinted from: corporate announcement editor: crystal

on september 23, shijiazhuang pharmaceutical innovations, namely sinopharm, issued an announcement that the company's board of directors had received written resignation reports from the company's chairman, mr. pan weidong, and director, mr. yang dong.

on september 23, shijiazhuang pharmaceutical innovations co., ltd. (sinovita) issued an announcement that the company's board of directors received a written resignation report from the company's chairman, mr. pan weidong.

due to job changes,mr. pan weidonghe applied to resign from the positions of chairman and director of the company, and concurrently as a member of the strategic committee and convener. after his resignation, he will no longer hold any position in the company. mr. pan weidong's original term of office was scheduled to expire on april 6, 2026, and his resignation report will take effect upon delivery to the board of directors.

at the same time, according to relevant laws and regulations and combined with the actual situation of the company, it is agreed to elect the company's directors and general managermr. yao binghe is the chairman of the sixth board of directors of the company, and his term of office will be from the date of approval by this board of directors to the expiration of the term of office of the sixth board of directors.

according to public information, pan weidong was born in december 1969 and holds a master's degree. he has worked for hebei pharmaceutical (group) co., ltd. and sino pharmaceutical. he is currently the executive director of cspc pharmaceutical group and the vice chairman of cspc pharmaceutical holdings.

yao bing, male, born in may 1977, holds a doctorate degree. he has worked at cspc hebei zhongrun pharmaceutical co., ltd. and cspc zhongnuo pharmaceutical (shijiazhuang) co., ltd. he was the executive president of cspc and was appointed as the executive director of cspc on may 29, 2024.

the announcement also shows that due to job changes,mr. yang donghe applied to resign from the position of director of the company, the concurrent position of member of the audit committee, and the concurrent position of member of the remuneration and appraisal committee. after his resignation, he will no longer hold any position in the company.

this year, shijiao innovation pharmaceutical has experienced frequent personnel changes. in april, news came that the company's general manager mr. han feng and director mr. wang huaiyu had resigned.